Seegene Technologies is the US based innovation division of Seegene Inc., a global developer of molecular technologies and high multiplex real-time PCR assays. Seegene molecular diagnostic solutions can simultaneously detect multiple targets with high accuracy for infectious diseases, respiratory infections and STDs. Seegene’s SARS-CoV-2- (COVID-19) Assay is FDA EUA.